A team led by Cara Croft, Ph.D., has demonstrated a novel method to model Alzheimer’s disease and Parkinson’s disease pathologies and seek potential therapeutic targets. Learn more:
In the journal Science, MBI leaders Drs. Steven DeKosky and Todd Golde discuss the challenges of developing effective Alzheimer's therapies and the road ahead.
MBI and 1Florida ADRC Director Todd Golde, M.D., Ph.D., shines light on UF’s role in a nationwide initiative to combat the disease and his hopes for the future
Retired Col. Dr. Michael Jaffee and Dr. Steven DeKosky explain military-related risks of developing dementia that are detailed in a new paper in the journal Alzheimer’s & Dementia.
Following Sandra Day O'Connor's announcement of her dementia, and possibly Alzheimer's, diagnosis, Dr. Todd Golde explains a dementia diagnosis, current treatments and his hope for the future.
The vulnerability of particular brain regions in old age that are important for problem-solving and reasoning.
Bill Gates recently invested in a venture fund to improve diagnostic testing for Alzheimer's. Steven DeKosky, M.D., discusses the importance of an early diagnosis for patients and researchers.
Glenn Smith, Ph.D., ABPP-cn, chair of the department of clinical and health psychology, recently commented on the state of Alzheimer's disease research in a Citrus County Chronicle feature story.